Abstract
Purpose
Venous thromboembolism (VTE) is a known cause of morbidity in the oncology patient population. As hospital readmission rates are more frequently scrutinized, we sought to determine the most common causes of 30-day readmissions in the cancer patient following abdominopelvic surgery. Furthermore, due to the high risk of VTE, there have been guidelines established for prophylaxis. As guidelines are based on asymptomatic VTE, we studied the compliance rates of these guidelines in our institution and the rate of symptomatic VTE in the 30-day postoperative period.
Methods
We conducted a retrospective chart review at Pennsylvania Hospital of abdominopelvic surgeries between January 1, 2010 and December 31, 2012 in patients with abdominopelvic malignancies, totaling 263 patients.
Results
The median age of our patient population was 67 years and 51.3 % were female. The most common malignancy locations were colorectal (44 %) and pancreas (11 %). One patient did not receive perioperative anticoagulation; most received heparin subcutaneously three times daily, mean duration 5.5 days. Fourteen patients (5 %) received outpatient anticoagulation after discharge; only two had a primary intent of VTE prophylaxis. Thirty-five patients (13 %) were readmitted within 30 days of discharge, the most common reasons being abdominal symptoms and postoperative/surgical complications. There was one patient readmitted for a new, symptomatic VTE.
Conclusions
Our study showed only one new, symptomatic VTE in the study population, despite 95 % of patients not receiving outpatient anticoagulation, which suggests that continued larger and multicenter trials may be needed to study anticoagulation benefits and risks in this patient population.
Similar content being viewed by others
Abbreviations
- VTE:
-
Venous thromboembolism
- ASCO:
-
American Society of Clinical Oncology
- UFH:
-
Unfractionated heparin
- LMWH:
-
Low-molecular-weight heparin
- DVT:
-
Deep venous thrombosis
- UPHS:
-
University of Pennsylvania Health System
- IRB:
-
Internal review board
- BMI:
-
Body mass index
- PE:
-
Pulmonary embolism
- NOS:
-
Not otherwise specified
- g:
-
Grams
- dL:
-
Deciliter
- L:
-
Liter
- mg:
-
Milligrams
- ACCP:
-
American College of Chest Physicians
References
Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243:89–95
Khorana AA (2012) Cancer-associated thrombosis: updates and controversies. In: Burns LJ (ed) Hematology Am Soc Hematol Educ Program 2012. American Society of Hematology, Rochester, pp 626–630
Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E (2004) Outcomes and cost of deep vein thrombosis among patients with cancer. Arch Intern Med 164:1653–1661
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189–2204
Rasmussen MS, Jorgensen LN, Wille-Jorgenson P (2009) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 1, CD004318
Akl EA, Terrenato I, Barba M, Sperati F, Muti P, Schunemann HJ (2008) Extended perioperative thromboprophylaxis in patients with cancer: a systematic review. Thromb Haemost 100:1176–1180
Stefan MS, Pekow PS, Nsa W, Priya A, Miller LE, Bratzler DW, Rothberg MB, Goldberg RJ, Baus K, Lindenauer PK (2013) Hospital performance measures and 30-day readmission rates. J Gen Intern Med 28:377–385
Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM (2012) Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg 214:390–398
Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A, Scoggins CR, McMasters KM (2011) Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab. Ann Surg 254:591–597
Rosemurgy AS, Luberice K, Paul H, Co F, Vice M, Toomey P, Choung E, Ross SB (2012) Readmissions after pancreaticoduodenectomy: efforts need to focus on patient expectations and nonhospital medical care. Am Surg 78:837–843
Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e227S–277S
Davenport DL, Vargas HD, Kasten MW, Xenos ES (2012) Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb Hemost 18:569–575
Toledano TH, Kondal D, Kahn SR, Tagalakis V (2013) The occurrence of venous thromboembolism in cancer patients following major surgery. Thromb Res 131:e1–e5
Smith BR, Diniz S, Stamos M, Nguyen NT (2011) Deep venous thrombosis after general surgical operations at a university hospital: two-year data from the ACS NSQIP. Arch Surg 146:1424–1427
Varpe P, Huhtinen H, Rantala A, Gronross J (2009) Thromboprophylaxis following surgery for colorectal cancer – is it worthwhile after hospital discharge? Scand J Surg 98:58–61
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907
Michota FA (2009) Prevention of venous thromboembolism after surgery. Cleve Clin J Med 76:S45–S52
Bradley CT, Brasel KJ, Miller JJ, Pappas SG (2010) Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol 17:31–39
Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355:1295–1302
Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T et al (2013) Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 158:800–806
Bilimoria KY, Chung J, Ju MH, Haut ER, Bentrem DJ, Ko CY, Baker DW (2013) Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA 310:1482–1489
Conflict of interest
Authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
White, C.K., Langholtz, J., Burns, Z.T. et al. Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review. Support Care Cancer 23, 993–999 (2015). https://doi.org/10.1007/s00520-014-2448-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2448-0